antiviral Archives - Journal for Clinical Studies

Current Edition

Regional News

SK advances Gates-backed COVID-19 antiviral spray toward clinic

SK bioscience is stepping up work on a nasal spray to prevent and treat COVID-19. With the Bill & Melinda Gates Foundation kicking in cash, the Korean biotech is ...

20 April 2022 Regional News antiviral | COVID

Continue Reading →

Regional News

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine

The COVID-19 pandemic is creating a $100 billion pharma goliath. Pfizer’s revenue could reach $101.3 billion in 2022, with major contributions coming from the compan...

24 November 2021 Regional News antiviral | BioNTech

Continue Reading →

Uncategorized

ViiV trials long-acting, two-drug HIV regimen

ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults w...

29 November 2017 Uncategorized antiviral | HIV

Continue Reading →

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Decentralised Clinical Trials in The EU

RWS – eBook

It’s All About Stem Cells

Covid-19

Current Edition

SK advances Gates-backed COVID-19 antiviral spray toward clinic

Pfizer to become $100B behemoth next year thanks to COVID-19 drug and vaccine

ViiV trials long-acting, two-drug HIV regimen

Journal for Clinical Studies